Estimating HCV prevalence at the state level: A call to increase and strengthen current surveillance systems

American Journal of Public Health

Volumn 103, Issue 8, 2013, Pages 1402-1405

  Hart Malloy, Rachel ^a,b   Carrascal, Alvaro ^b   DiRienzo, A Gregory ^b   Flanigan, Colleen ^a   McClamroch, Kristi ^b   Smith, Lou ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEALTH SURVEY; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NUTRITION; PREVALENCE; REGISTER; UNITED STATES;

ADULT; AGED; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; UNITED STATES;

EID: 84880180352     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301231     Document Type: Article

References (51)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.
2. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012;55(6):1652-1661.
3. Committee on the Prevention and Control of Viral Hepatitis Infection, Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; 2010.
4. Deniz B, Pyrenson B, Iwasaki K, Graham CS. Hepatitis C virus (HCV) testing and diagnosis rates in the commercially insured and Medicare populations in the US. Paper presented at: the 139th American Public Health Association Annual Meeting; October 29- November 2, 2011; Washington, DC. Available at: https://apha.confex.com/apha/139am/webprogram/Paper246241.html. Accessed November 4, 2011.
5. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341 (8):556-562.
6. Edlin BR. Perspective: test and treat this silent killer. Nature. 2011;474(7350):S18-S19.
7. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47-52.
8. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9(4):331-338.
9. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011;31(8):1090-1101.
10. Bornschlegel K, Berger M, Garg RK, et al. Prevalence of hepatitis C infection in New York City, 2004. J Urban Health. 2009;86(6):909-917.
11. National Health and Nutrition Examination Survey. Questionnaires, datasets, and related documentation. Centers for Disease Control and Prevention, National Center for Health Statistics. 2010. Available at: http://www.cdc.gov/ nchs/nhanes/nhanes-questionnaires.htm. Accessed May 20, 2010.
12. National Health and Nutrition Examination Survey. NHANES 2007-2008 laboratory files. Centers for Disease Control and Prevention, National Center for Health Statistics. 2010. Available at: http://www.cdc.gov/nchs/nhanes/ nhanes2007-2008/lab07-08.htm. Accessed May 20, 2010.
13. Poverty methodology, definitions. US Census Bureau. Available at: http://www.census.gov/hhes/www/poverty/methods/definitions.html#ratio%20of %20income%20to%20poverty. Accessed May 22, 2010.
14. A Compass for Understanding and Using American Community Survey Data: What PUMS Data Users Need to Know. Washington, DC: US Census Bureau; 2009. Available at: http://www.census.gov/acs/www/Downloads/handbooks/ACSPUMS.pdf. Accessed February 1, 2012.
15. Ruiz JD, Molitor F, Sun RK, et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med. 1999;170(3):156-160.
16. Lanphear BP. Trends and patterns in the transmission of bloodborne pathogens to health care workers. Epidemiol Rev. 1994;16(2):437-450.
17. Kelen GD, Green GB, Purcell RH, et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med. 1992;326(21):1399-1404.
18. Hall MR, Ray D, Payne JA. Prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a Grand Rapids, Michigan emergency department. J Emerg Med. 2010;38(3):401-405.
19. Meyer JM. Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry. 2003;64(5):540-545.
20. Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clin Infect Dis. 2005;40(suppl 5):S330-S335.
21. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000;95(3):740-747.
22. Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis. 2001;20(4):17-27.
23. Desai RA, Rosenheck RA, Agnello V. Prevalence of hepatitis C virus infection in a sample of homeless veterans. Soc Psychiatry Psychiatr Epidemiol. 2003;38 (7):396-401.
24. Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002;34 (4):476-480.
25. Nyamathi AM, Dixon EL, Robbins W, et al. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med. 2002;17(2):134-143.
26. Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44(4):293-302.
27. Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend. 2004;75(1):89-95.
28. Schwarz KB, Garrett B, Alter MJ, Thompson D, Strathdee SA. Seroprevalence of HCV infection in homeless Baltimore families. J Health Care Poor Underserved. 2008;19(2):580-587.
29. Hyams KC, Riddle J, Rubertone M, et al. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops. Am J Epidemiol. 2001;153(8):764-770.
30. Brillman JC, Crandall CS, Florence CS, Jacobs JL. Prevalence and risk factors associated with hepatitis C in ED patients. Am J Emerg Med. 2002;20(5):476-480.
31. Chien NT, Dundoo G, Horani MH, Osmack P, Morley JH, Di Bisceglie AM. Seroprevalence of viral hepatitis in an older nursing home population. J Am Geriatr Soc. 1999;47(9):1110-1113.
32. Ruiz JD, Molitor F, Plagenhoef JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS. 2002;16 (16):2236-2238.
33. Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117(1):43-48.
34. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81(1):25-37.
35. Macalino GE, Dhawan D, Rich JD. A missed opportunity: hepatitis C screening of prisoners. Am J Public Health. 2005;95(10):1739-1740.
36. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005;41(2):177-186.
37. Statewide Planning and Research Cooperative System (SPARCS) overview. New York State Department of Health. 2007. Available at: http://www.health.ny.gov/ statistics/sparcs/operations/overview.htm. Accessed December 20, 2010.
38. Fast facts about nursing facilities. New York State Health Facilities Association Inc. 2010. Available at: http://www.nyshfa.org/consumers/nursing- facility-facts. asp. Accessed January 10, 2010.
39. Public use microdata sample. US Census Bureau, American Community Survey. 2011. Available at: http://www.census.gov/acs/www/data-documentation/public- use-microdata-sample. Accessed January 30, 2011.
40. US Dept of Housing and Urban Development, Office of Community Planning and Development. The 2009 annual homeless assessment report to Congress. 2009. Available at: http://www.hudhre.info/documents/5thHomelessAssessmentReport.pdf. Accessed January 10, 2010.
41. State of New York Department of Correctional Services. 2009. Under custody report: profile of inmate population under custody on January 1, 2009. Available at: http://www.prisonpolicy.org/scans/nydocs/UnderCustody-Report2009. pdf. Accessed December 20, 2010.
42. Rocchio E, Bornschlegel K. Hepatitis C surveillance: comparison of the New York State and New York City systems. Presented at: New York State HCV Advisory Council meeting; September 22, 2008; Albany, NY.
43. Colodner M, ed. New York State Public Health Legal Manual: A Guide for Judges, Attorneys and Public Health Professionals. Albany, NY: New York State Bar Association, New York State Unified Court System; 2011. Available at: http://www.nycourts.gov/whatsnew/pdf/PublicHealthLegalManual.pdf. Accessed December 3, 2012.
44. Laboratory reporting of 2012 communicable diseases. New York State Department of Health, New York City Department of Health and Mental Hygiene. 2010. Available at: http://www.wadsworth.org/labcert/regaffairs/clinical/ commdiseaseguide.pdf. Accessed December 3, 2012.
45. Campbell KM. Rule your data with The Link King. Paper presented at: Pacific Northwest SAS Users Group Conference; October 1, 2004; Seattle, WA. Paper 020-30. Available at: http://www2.sas.com/proceedings/sugi30/020-30.pdf. Accessed February 12, 2011.
46. France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S. Estimating the prevalence of chronic hepatitis b virus infection-New York City, 2008. J Urban Health. 2012;89(2):373-383.
47. Centers for Disease Control and Prevention. Current and historical public health surveillance condition list with shading to indicate nationally notifiable condition by year, 1992-2013. 2010. Available at: http://wwwn.cdc.gov/nndss/document/NNDSS-history-spreadsheet-2013-for-web-v1. pdf. Accessed December 20, 2012.
48. Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K. Estimating the prevalence of injection drug users in the US and in large US metropolitan areas from 1992 to 2002. J Urban Health. 2008;85 (3):323-351.
49. Mitchell AE, Colvin HM, Palmer BR. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010;51(3):729-733.
50. Iqbal K, Klevens RM, Jiles R. Comparison of acute viral hepatitis data quality using two methodologies, 2005-2007. Public Health Rep. 2012;127(6):591-597.
51. Klevens RM, Miller J, Vonderwahl C, et al. Population-based surveillance for hepatitis C virus, United States, 2006-2007. Emerg Infect Dis. 2009;15 (9):1499-1502.